After a three-year hearing, India’s patent office has rejected an application filed by US drug multinational Abbott Laboratories for its anti-HIV drug Aluvia, a combination of the drugs lopinavir and ritonavir, according to a copy of the decision seen by Mint on Monday. Livemint